Literature DB >> 16470747

Angelman syndrome 2005: updated consensus for diagnostic criteria.

Charles A Williams1, Arthur L Beaudet, Jill Clayton-Smith, Joan H Knoll, Martin Kyllerman, Laura A Laan, R Ellen Magenis, Ann Moncla, Albert A Schinzel, Jane A Summers, Joseph Wagstaff.   

Abstract

In 1995, a consensus statement was published for the purpose of summarizing the salient clinical features of Angelman syndrome (AS) to assist the clinician in making a timely and accurate diagnosis. Considering the scientific advances made in the last 10 years, it is necessary now to review the validity of the original consensus criteria. As in the original consensus project, the methodology used for this review was to convene a group of scientists and clinicians, with experience in AS, to develop a concise consensus statement, supported by scientific publications where appropriate. It is hoped that this revised consensus document will facilitate further clinical study of individuals with proven AS, and assist in the evaluation of those who appear to have clinical features of AS but have normal laboratory diagnostic testing.

Entities:  

Mesh:

Year:  2006        PMID: 16470747     DOI: 10.1002/ajmg.a.31074

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  168 in total

1.  Sleep in children and adolescents with Angelman syndrome: association with parent sleep and stress.

Authors:  S E Goldman; T J Bichell; K Surdyka; B A Malow
Journal:  J Intellect Disabil Res       Date:  2011-11-02

2.  Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

Authors:  Richard M Gustin; Terry Jo Bichell; Michael Bubser; Jennifer Daily; Irina Filonova; Davit Mrelashvili; Ariel Y Deutch; Roger J Colbran; Edwin J Weeber; Kevin F Haas
Journal:  Neurobiol Dis       Date:  2010-04-25       Impact factor: 5.996

3.  Neuroscience: Angelman syndrome connections.

Authors:  Peter Scheiffele; Asim A Beg
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

Review 4.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

5.  Infants relax in response to unfamiliar foreign lullabies.

Authors:  Constance M Bainbridge; Mila Bertolo; Julie Youngers; S Atwood; Lidya Yurdum; Jan Simson; Kelsie Lopez; Feng Xing; Alia Martin; Samuel A Mehr
Journal:  Nat Hum Behav       Date:  2020-10-19

6.  A therapeutic trial of pro-methylation dietary supplements in Angelman syndrome.

Authors:  Lynne M Bird; Wen-Hann Tan; Carlos A Bacino; Sarika U Peters; Steven A Skinner; Irina Anselm; Rene Barbieri-Welge; Astrid Bauer-Carlin; Jennifer K Gentile; Daniel G Glaze; Lucia T Horowitz; K Naga Mohan; Mark P Nespeca; Trilochan Sahoo; Dean Sarco; Susan E Waisbren; Arthur L Beaudet
Journal:  Am J Med Genet A       Date:  2011-10-14       Impact factor: 2.802

7.  N-glycosylation in regulation of the nervous system.

Authors:  Hilary Scott; Vladislav M Panin
Journal:  Adv Neurobiol       Date:  2014

8.  Ube3a imprinting impairs circadian robustness in Angelman syndrome models.

Authors:  Shu-qun Shi; Terry Jo Bichell; Rebecca A Ihrie; Carl Hirschie Johnson
Journal:  Curr Biol       Date:  2015-02-05       Impact factor: 10.834

9.  Sex-Dependent Sensory Phenotypes and Related Transcriptomic Expression Profiles Are Differentially Affected by Angelman Syndrome.

Authors:  Lee Koyavski; Julia Panov; Lilach Simchi; Prudhvi Raj Rayi; Lital Sharvit; Yonatan Feuermann; Hanoch Kaphzan
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

10.  Impairment of TrkB-PSD-95 signaling in Angelman syndrome.

Authors:  Cong Cao; Mengia S Rioult-Pedotti; Paolo Migani; Crystal J Yu; Rakesh Tiwari; Keykavous Parang; Mark R Spaller; Dennis J Goebel; John Marshall
Journal:  PLoS Biol       Date:  2013-02-12       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.